Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,500
Closed -$5.89M – 1073
2022
Q4
$5.89M Buy
+11,500
New +$6.04M 0.03% 356

Other funds holding HUM

Natixis's HUM Position: Q2 2026 in Review

Natixis reduced its Humana (HUM) stake by 90% in Q2 2026, selling an estimated $30.3M and leaving 12,239 shares worth $4.86M. The position accounts for 0.02% of the portfolio, ranked #442.

Natixis first reported a position in HUM in Q4 2013 and has held it in 45 quarters since. The position peaked at $138M in Q3 2018. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Natixis held 12,239 shares of Humana worth $4.86M as of Q2 2026.
  • Natixis sold 106,400 Humana shares in Q2 2026, an estimated $30.3M.
  • Humana made up 0.02% of Natixis's portfolio in Q2 2026, its #442 holding.
  • Natixis first reported a position in Humana in Q4 2013 and has held it in 45 quarters since.
  • Natixis's Humana position peaked at $138M in Q3 2018.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.